Welcome to the InfoSci Platform
Diagnosing Methods of Parkinson's Disease: Revolutionary Techniques

Diagnosing Methods of Parkinson's Disease: Revolutionary Techniques

Hafida El Ghachi, Mjid Oukhrib, Lahcen Tamegart, Abdelali Ben Maloui, Bilal El-Mansoury, Halima Gamrani
Copyright: © 2023 |Pages: 18
ISBN13: 9781668451564|ISBN10: 1668451565|EISBN13: 9781668451571
DOI: 10.4018/978-1-6684-5156-4.ch004
Cite Chapter Cite Chapter

MLA

El Ghachi, Hafida, et al. "Diagnosing Methods of Parkinson's Disease: Revolutionary Techniques." Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, et al., IGI Global, 2023, pp. 46-63. https://doi.org/10.4018/978-1-6684-5156-4.ch004

APA

El Ghachi, H., Oukhrib, M., Tamegart, L., Ben Maloui, A., El-Mansoury, B., & Gamrani, H. (2023). Diagnosing Methods of Parkinson's Disease: Revolutionary Techniques. In A. Draoui, O. El Hiba, & A. Jayakumar (Eds.), Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease (pp. 46-63). IGI Global. https://doi.org/10.4018/978-1-6684-5156-4.ch004

Chicago

El Ghachi, Hafida, et al. "Diagnosing Methods of Parkinson's Disease: Revolutionary Techniques." In Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, Omar El Hiba, and Arumugam R. Jayakumar, 46-63. Hershey, PA: IGI Global, 2023. https://doi.org/10.4018/978-1-6684-5156-4.ch004

Export Reference

Mendeley
Favorite

Abstract

Parkinson's disease is known by tremor, rigidity, and bradykinesia. Non-motor symptoms also manifest during the disease course or even predate the appearance of motor-symptoms and that can be as troublesome as motor features. At the cellular level, the degeneration of substantia nigra neurons and the low levels of dopamine caused by intracytoplasmic inclusions of Lewy bodies that consist of α-synuclein were recognized as the putative cause of the disease and therefore physical symptoms. PD is a slow-moving illness and detection of that disease is not easy because of delayed symptoms, variation in clinical manifestations, course of progression, and biomarker profiles from person to person. Early diagnosis of PD plays a critical role in effective disease management. Here, the authors aim to give an overview of different methods of diagnosing PD with emphasis on clinical differential diagnosis that differentiate it from other parkinsonian disorders, challenges, and a brief description of new approaches of artificial intelligence technologies as a tool for better prediction of that disease.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.